Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01AJM
|
|||
| Former ID |
DIB017006
|
|||
| Drug Name |
YP-009
|
|||
| Synonyms |
RPL-208; Cyclopentenone prostaglandin mimetic (PGM) (cancer), Rosanto; Cyclopentenone prostaglandin mimetic (PGM) (cancer), York Pharma
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
Rosanto Pharmaceuticals Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Prostaglandin receptor (PTGR) | Target Info | Agonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026449) | |||
| REF 2 | YP 009 York Pharma pc preclinical, UK(cancer), R & D Focus Drug News, November 12, 2007 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.